Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 39: 625-628, 1993;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schleicher, E. D.
Right arrow Articles by Gerbitz, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schleicher, E. D.
Right arrow Articles by Gerbitz, K. D.

Clinical Chemistry, Vol 39, 625-628, Copyright © 1993 by American Association for Clinical Chemistry

Specific glycation of albumin depends on its half-life

ED Schleicher, B Olgemoller, E Wiedenmann and KD Gerbitz
Institute for Diabetes Research, Munich, Germany.

Some suggest that measurements of plasma fructosamine concentration should be corrected for the plasma protein (or albumin) concentration because the extent of glycation per volume depends on both protein and glucose concentrations. Several reports, however, demonstrate a poor correlation between plasma fructosamine and albumin concentrations in diabetic patients. In vitro kinetic and in vivo studies have shown that glycation is also dependent on the half-lives of plasma proteins. Because a decrease in plasma albumin diminishes its catabolism, we speculated that low albumin concentrations are associated with a greater extent of glycation on a molar basis (specific glycation) and vice versa. To test this hypothesis, we studied plasma albumin, total protein, and fructosamine in 63 nondiabetic subjects with normal plasma fasting glucose concentrations and hemoglobin A1c between 5.1% and 5.9%. Plasma fructosamine was poorly correlated with albumin concentration (r = 0.348) but a logarithmic plot of the specific glycation of albumin vs albumin concentration showed a better correlation (r = -0.842), suggesting that the kinetic considerations were operating in vivo. Therefore, because lower specific glycation of plasma albumin "compensates" for higher concentration, correction of fructosamine for albumin content in patients will overestimate mean blood glucose when albumin is low and underestimate it when albumin is high.


The following articles in journals at HighWire Press have cited this article:


Home page
 J. Am. Soc. Nephrol.Home page
M. Inaba, S. Okuno, Y. Kumeda, S. Yamada, Y. Imanishi, T. Tabata, M. Okamura, S. Okada, T. Yamakawa, E. Ishimura, et al.
Glycated Albumin Is a Better Glycemic Indicator than Glycated Hemoglobin Values in Hemodialysis Patients with Diabetes: Effect of Anemia and Erythropoietin Injection
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 896 - 903.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
Y. Wang, C. Dou, C. Yuan, and A. Datta
Development of an Automated Enzymatic Assay for the Determination of Glycated Serum Protein in Human Serum
Clin. Chem., October 1, 2005; 51(10): 1991 - 1992.
[Full Text] [PDF]

Home page
 QJMHome page
K. Wiener and N.B. Roberts
Age does not influence levels of HbA1c in normal subject
QJM, March 1, 1999; 92(3): 169 - 173.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Association for Clinical Chemistry.